Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin succinate for overactive bladder in inner city women
NCT00773552Phase 4Withdrawn
- Sponsor
- Stamford Hospital
- Start
- Nov 2008
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by Stamford Hospital. Planned start Nov 2008; status: withdrawn.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00773552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773552.